Session Details

F104 Hair Disorders Made Easier

Mon, Mar 30, 3:30 PM - 5:30 PM
Four Seasons 1
2 CME Available Forum Upcoming
View Map

DESCRIPTION

This session will empower dermatologists to provide a practical approach to hair disorders, focused on the key differential diagnosis and types of therapy. From getting the most out of your biopsy reports and utilizing trichoscopy to learning the best therapeutic pearls from expert alopecia specialists, this session will be a "one stop" for all things you want to learn about diagnosing and managing patients with non-scarring and scarring alopecia.

LEARNING OBJECTIVES

1.

Develop an approach to assessing and monitoring patients with hair loss disorders

2.

Formulate therapeutic approaches and develop effective treatment plans for patients with scarring and non-scarring alopecia

3.

Utilize therapeutic pearls based on expert clinical experience

SCHEDULE

3:30 PM

Getting the most from your alopecia pathology reports

Lynne J. Goldberg, MD, FAAD

3:40 PM

Trichoscopy 101 for Alopecia Diagnoses

Rodrigo Pirmez, MD

3:50 PM

Treatment of Female Pattern Hair Loss

Paulo Müller Ramos, MD, IFAAD

4:00 PM

Frontal Fibrosing Alopecia: My Therapeutic Approach

Daniel Asz-Sigall, MD, IFAAD

4:10 PM

Treatment of Lichen Planopilaris

Isabella Doche, MD, PhD, IFAAD

4:20 PM

Treatment of Male Androgenetic Alopecia

Luis Enrique Sanchez Duenas, MD

4:30 PM

Mesotherapy and Botox for Non-Scarring Hair Loss

Daniel Melo, MD, MS, PhD, IFAAD

4:40 PM

Treatment of Neutrophilic Scarring Alopecia

Lidia Rudnicka, MD, PhD, IFAAD

4:50 PM

Alopecia Areata: JAK Inhibitor Treatment Pearls

Anastasia Therianou, MD, PhD, IFAAD

5:00 PM

Lasers, Lights, and PRP for the Treatment of Alopecia

Joseph W. Fakhoury, MD, FAAD

5:10 PM

Hair Transplantation: When to consider it and FAQs for the dermatologist

Nicole Elaine Rogers, MD, FAAD

5:20 PM

Questions and Answers

DIRECTOR

Joseph W. Fakhoury, MD, FAAD

Joseph W. Fakhoury, MD, FAAD

SPEAKERS

Daniel Asz-Sigall, MD, IFAAD

Daniel Asz-Sigall, MD, IFAAD

Isabella Doche, MD, PhD, IFAAD

Isabella Doche, MD, PhD, IFAAD

Lynne J. Goldberg, MD, FAAD

Lynne J. Goldberg, MD, FAAD

Daniel Melo, MD, MS, PhD, IFAAD

Daniel Melo, MD, MS, PhD, IFAAD

Paulo Müller Ramos, MD, IFAAD

Paulo Müller Ramos, MD, IFAAD

Rodrigo Pirmez, MD

Rodrigo Pirmez, MD

Nicole Elaine Rogers, MD, FAAD

Nicole Elaine Rogers, MD, FAAD

Lidia Rudnicka, MD, PhD, IFAAD

Lidia Rudnicka, MD, PhD, IFAAD

Luis Enrique Sanchez Duenas, MD

Luis Enrique Sanchez Duenas, MD

Anastasia Therianou, MD, PhD, IFAAD

Anastasia Therianou, MD, PhD, IFAAD

DISCLOSURES

Daniel Asz-Sigall, MD, IFAAD

No financial relationships exist with ineligible companies.

Isabella Doche, MD, PhD, IFAAD

Ache Laboratório Farmaceuticso S.A. – Speaker/Faculty Education(Fees); Cantabria Labs – Speaker/Faculty Education(Fees); Fotofinder – Other(Equipment); GlaxoSmithKline Immunology – Speaker/Faculty Education(Fees); L'Oreal – Speaker/Faculty Education(Fees); Mantecorp – Consultant (1099 relationship)(Fees); Panalab – Speaker/Faculty Education(Fees); Pfizer Inc. – Advisory Board(Fees), Speaker/Faculty Education(Fees); Pierre Fabre – Speaker/Faculty Education(Fees); TheraSkin Farmacêutica – Consultant (1099 relationship)(Fees);

Joseph W. Fakhoury, MD, FAAD

No financial relationships exist with ineligible companies.

Lynne J. Goldberg, MD, FAAD

UpToDate, Inc – Other(Fees);

Daniel Melo, MD, MS, PhD, IFAAD

No financial relationships exist with ineligible companies.

Paulo Müller Ramos, MD, IFAAD

Ache Laboratório Farmaceuticso S.A. – Advisory Board(Fees); Farmoquímica S.A. (FQM) – Speaker(Fees); L'Oreal – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); TheraSkin Farmacêutica – Speaker(Fees);

Rodrigo Pirmez, MD

Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); Eli Lilly and Company – Consultant(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees); Vichy Laboratoires – Speaker(Fees);

Nicole Elaine Rogers, MD, FAAD

No financial relationships exist with ineligible companies.

Lidia Rudnicka, MD, PhD, IFAAD

La Roche-Posay Laboratoire Pharmaceutique – Speaker(Fees); Leo Pharma Inc – Speaker/Faculty Education(Fees); Pfizer Inc. – Advisory Board(Fees);

Luis Enrique Sanchez Duenas, MD

No financial relationships exist with ineligible companies.

Anastasia Therianou, MD, PhD, IFAAD

No financial relationships exist with ineligible companies.